To further validate a link between aberrant localization of nuclear proteins in AD neurons and RAN deficits, we conducted RAN knockdown experiments in SK-N-BE(2) neuroblastoma cells using an experimentally-determined optimum concentration of RAN siRNA of 100 nM. The gene discussed is RAN; the disease is Alzheimer disease.